Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Esra Yürümez, Çağatay Uğur & Mehmet Sertçelik. (2018) The assessment of serum omentin levels of children with autism spectrum disorder and attention-deficit/hyperactivity disorder. Psychiatry and Clinical Psychopharmacology 28:3, pages 268-275.
Read now
Read now
Monika Dvořáková, Daniela Ježová, Pavol Blažíček, Jana Trebatická, Igor Škodáček, Ján Šuba, Iveta Waczulíková, Peter Rohdewald & Zdeňka Ďuračková. (2007) Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): Modulation by a polyphenolic extract from pine bark (Pycnogenol®). Nutritional Neuroscience 10:3-4, pages 151-157.
Read now
Read now
Michele Germano, Domenico Meleleo, Gigliola Montorfano, Laura Adorni, Manuela Negroni, Bruno Berra & Angela M. Rizzo. (2007) Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD). Nutritional Neuroscience 10:1-2, pages 1-9.
Read now
Read now
Satoshi Tamura, Hirokazu Tsukahara, Masaki Ueno, Masayuki Maeda, Hisako Kawakami, Kyouichi Sekine & Mitsufumi Mayumi. (2006) Evaluation of a urinary multi-parameter biomarker set for oxidative stress in
children, adolescents and young adults. Free Radical Research 40:11, pages 1198-1205.
Read now
Read now
Articles from other publishers (54)
Ali Güven Kılıçoğlu, Telli Zadehgan AfshordSongul DerinErdem ErtasPınar CoskunSelman AktasEray Metin Guler. (2023) Comparison of Possible Changes in Oxidative Stress, DNA Damage, and Inflammatory Markers in Children/Adolescents Diagnosed with Sluggish Cognitive Tempo and Children/Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 33:8, pages 325-331.
Crossref
Crossref
R. F. Gasanov, I. V. Makarov, D. A. Emelina & A. S. Avtenuk. (2023) Neuroinflammation and its role in the pathogenesis of attention deficit hyperactivity disorder (literature review). V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY 57:1, pages 8-22.
Crossref
Crossref
Ponmari Guruvaiya & Kalidass Subramaniam. 2023. Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach. Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach
55
65
.
Anne-Sophie Weyns, Annelies A.J. Verlaet, Maxim Van Herreweghe, Annelies Breynaert, Erik Fransen, Ingrid De Meester, Emilie Logie, Wim Vanden Berghe, Helene Verhelst, Dirk Van West, Ingrid Van Ingelghem, An I. Jonckheere, Diane Beysen, Sandra Kenis, Els Moens, Aalt P.J. van Roest, Huub F.J. Savelkoul, Tess De Bruyne, Luc Pieters, Berten Ceulemans & Nina Hermans. (2022) Clinical Investigation of French Maritime Pine Bark Extract on Attention-Deficit Hyperactivity Disorder as compared to Methylphenidate and Placebo: Part 2: Oxidative Stress and Immunological Modulation. Journal of Functional Foods 97, pages 105247.
Crossref
Crossref
Paola Bozzatello, Cecilia Blua, Paola Rocca & Silvio Bellino. (2021) Mental Health in Childhood and Adolescence: The Role of Polyunsaturated Fatty Acids. Biomedicines 9:8, pages 850.
Crossref
Crossref
Ken Yonezawa, Yuko Kusumoto, Nobukazu Kanchi, Hirohisa Kinoshita, Shinji Kanegae, Naohiro Yamaguchi & Hiroki Ozawa. (2020) Recent trends in mental illness and omega-3 fatty acids. Journal of Neural Transmission 127:11, pages 1491-1499.
Crossref
Crossref
Juan Carlos Corona. (2020) Role of Oxidative Stress and Neuroinflammation in Attention-Deficit/Hyperactivity Disorder. Antioxidants 9:11, pages 1039.
Crossref
Crossref
Ramya Selvaraj, Nilesh J. Vasa, S. M. Shiva Nagendra & Boris Mizaikoff. (2020) Advances in Mid-Infrared Spectroscopy-Based Sensing Techniques for Exhaled Breath Diagnostics. Molecules 25:9, pages 2227.
Crossref
Crossref
Annelies A. J. Verlaet, Annelies Breynaert, Berten Ceulemans, Tess De Bruyne, Erik Fransen, Luc Pieters, Huub F. J. Savelkoul & Nina Hermans. (2018) Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case–control comparison. European Child & Adolescent Psychiatry 28:5, pages 719-729.
Crossref
Crossref
Fereidoon ShahidiPriyatharini Ambigaipalan. (2018) Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits. Annual Review of Food Science and Technology 9:1, pages 345-381.
Crossref
Crossref
Annelies Verlaet, Carlijn Maasakkers, Nina Hermans & Huub Savelkoul. (2018) Rationale for Dietary Antioxidant Treatment of ADHD. Nutrients 10:4, pages 405.
Crossref
Crossref
Annelies A. J. Verlaet, Berten Ceulemans, Helene Verhelst, Dirk Van West, Tess De Bruyne, Luc Pieters, Huub F. J. Savelkoul & Nina Hermans. (2017) Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial. Trials 18:1.
Crossref
Crossref
R. Grant & J. Guest. 2016. The Benefits of Natural Products for Neurodegenerative Diseases. The Benefits of Natural Products for Neurodegenerative Diseases
247
274
.
Janet K. Kern, David A. Geier, Lisa K. Sykes, Mark R. Geier & Richard C. Deth. (2012) Are ASD and ADHD a Continuum? A Comparison of Pathophysiological Similarities Between the Disorders. Journal of Attention Disorders 19:9, pages 805-827.
Crossref
Crossref
Fátima de Heredia, Ligia Díaz, Aurora Hernández, Ana Veses, Sonia Gómez-Martínez & Ascensión Marcos. 2015. Antioxidants in Health and Disease. Antioxidants in Health and Disease
53
70
.
Salik Selek & M. Fatih Ceylan. 2015. Studies on Psychiatric Disorders. Studies on Psychiatric Disorders
143
150
.
Brian Ross & Iain Glen. (2014) Breath Ethane Concentrations in Healthy Volunteers Correlate with a Systemic Marker of Lipid Peroxidation but Not with Omega-3 Fatty Acid Availability. Metabolites 4:3, pages 572-579.
Crossref
Crossref
Eric Gumpricht & Susie Rockway. (2014) Can ω-3 fatty acids and tocotrienol-rich vitamin E reduce symptoms of neurodevelopmental disorders?. Nutrition 30:7-8, pages 733-738.
Crossref
Crossref
Scott S. Field. (2014) Interaction of genes and nutritional factors in the etiology of autism and attention deficit/hyperactivity disorders: A case control study. Medical Hypotheses 82:6, pages 654-661.
Crossref
Crossref
Ai-hua Cao, Lin Yu, Yu-wei Wang, Gui-ju Wang & Ge-fei Lei. (2013) Composition of long chain polyunsaturated fatty acids (LC-PUFAs) in different encephalic regions and its association with behavior in spontaneous hypertensive rat (SHR). Brain Research 1528, pages 49-57.
Crossref
Crossref
Joanne Bradbury. 2013. Advances in Natural Medicines, Nutraceuticals and Neurocognition. Advances in Natural Medicines, Nutraceuticals and Neurocognition
165
202
.
Catherine Transler, Siobhan Mitchell & Ans Eilander. (2011) Could Polyunsaturated Fatty Acids Deficiency Explain Some Dysfunctions Found in ADHD? Hypotheses From Animal Research. Journal of Attention Disorders 17:1, pages 20-28.
Crossref
Crossref
S. Yehuda. (2012) Polyunsaturated fatty acids as putative cognitive enhancers. Medical Hypotheses 79:4, pages 456-461.
Crossref
Crossref
Pedro Luis Prior & José Carlos Fernandes Galduróz. (2012) (N-3) Fatty Acids: Molecular Role and Clinical Uses in Psychiatric Disorders. Advances in Nutrition 3:3, pages 257-265.
Crossref
Crossref
Laura V. Dishaw, Christina M. Powers, Ian T. Ryde, Simon C. Roberts, Frederic J. Seidler, Theodore A. Slotkin & Heather M. Stapleton. (2011) Is the PentaBDE replacement, tris (1,3-dichloro-2-propyl) phosphate (TDCPP), a developmental neurotoxicant? Studies in PC12 cells. Toxicology and Applied Pharmacology 256:3, pages 281-289.
Crossref
Crossref
S Yehuda, S Rabinovitz-Shenkar & R L Carasso. (2011) Effects of essential fatty acids in iron deficient and sleep-disturbed attention deficit hyperactivity disorder (ADHD) children. European Journal of Clinical Nutrition 65:10, pages 1167-1169.
Crossref
Crossref
Brian M. Ross, Ross Maxwell & Iain Glen. (2011) Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:2, pages 446-453.
Crossref
Crossref
Brian M. Ross, Sandeep Shah & Malcolm Peet. (2011) Increased breath ethane and pentane concentrations in currently unmedicated patients with schizophrenia. Open Journal of Psychiatry 01:01, pages 1-7.
Crossref
Crossref
J.P. Schuchardt & A. Hahn. 2011. Lifetime Nutritional Influences on Cognition, Behaviour and Psychiatric Illness. Lifetime Nutritional Influences on Cognition, Behaviour and Psychiatric Illness
32
78
.
Andreas Johannes Schmidt, Jürgen‐Christian Krieg, Ulrich Michael Hemmeter, Tilo Kircher, Eberhard Schulz, Hans‐Willi Clement & Philip Heiser. (2010) Impact of plant extracts tested in attention‐deficit/hyperactivity disorder treatment on cell survival and energy metabolism in human neuroblastoma SH‐SY5Y cells. Phytotherapy Research 24:10, pages 1549-1553.
Crossref
Crossref
Chris Chandler. 2010. The Science of ADHD. The Science of ADHD
240
326
.
Beth Levant, Troy J. Zarcone & Stephen C. Fowler. (2010) Developmental effects of dietary n−3 fatty acids on activity and response to novelty. Physiology & Behavior 101:1, pages 176-183.
Crossref
Crossref
Milica Bajčetić, Milan Brajović & Radojka Korkut-Tešić. (2010) Diagnostic and Therapeutic Significance of the Oxidative Stress Parameters in Children. Journal of Medical Biochemistry 29:3, pages 196-203.
Crossref
Crossref
Jan Philipp Schuchardt, Michael Huss, Manuela Stauss-Grabo & Andreas Hahn. (2009) Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. European Journal of Pediatrics 169:2, pages 149-164.
Crossref
Crossref
A.J. Russo. (2010) Decreased Serum Cu/Zn SOD Associated with High Copper in Children with Attention Deficit Hyperactivity Disorder (ADHD). Journal of Central Nervous System Disease 2, pages JCNSD.S4553.
Crossref
Crossref
Christopher J. Pavlovski. (2009) Screening for essential fatty acid deficiency in at risk infants. Medical Hypotheses 73:6, pages 910-916.
Crossref
Crossref
Alexa Hryniuk & Brian M. Ross. (2009) Detection of acetone and isoprene in human breath using a combination of thermal desorption and selected ion flow tube mass spectrometry. International Journal of Mass Spectrometry 285:1-2, pages 26-30.
Crossref
Crossref
Valencia Booth Porter. 2009. Food and Nutrients in Disease Management. Food and Nutrients in Disease Management.
J. M. Bourre. 2010. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology
409
441
.
Chris D. MeletisNieske Zabriskie. (2008) Attention-Deficit Hyperactivity Disorder. Alternative and Complementary Therapies 14:5, pages 235-242.
Crossref
Crossref
Schohraya Spahis, Michel Vanasse, Stacey A. Bélanger, Parviz Ghadirian, Emilie Grenier & Emile Levy. (2008) Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins, Leukotrienes and Essential Fatty Acids 79:1-2, pages 47-53.
Crossref
Crossref
Basant K Puri, Ian H Treasaden, Massimo Cocchi, Sofia Tsaluchidu, Lucio Tonello & Brian M Ross. (2008) A comparison of oxidative stress in smokers and non-smokers: an in vivo human quantitative study of n-3 lipid peroxidation. BMC Psychiatry 8:S1.
Crossref
Crossref
Basant K Puri, Serena J Counsell, Brian M Ross, Gavin Hamilton, Marcelo G Bustos & Ian H Treasaden. (2008) Evidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans. BMC Psychiatry 8:S1.
Crossref
Crossref
Basant K. Puri, Brian M. Ross & Ian H. Treasaden. (2008) Increased levels of ethane, a non-invasive, quantitative, direct marker of n-3 lipid peroxidation, in the breath of patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:3, pages 858-862.
Crossref
Crossref
Brian M. Ross & Natasha Vermeulen. (2007) The combined use of thermal desorption and selected ion flow tube mass spectrometry for the quantification of xylene and toluene in air. Rapid Communications in Mass Spectrometry 21:22, pages 3608-3612.
Crossref
Crossref
. (2007) Attention-deficit/Hyperactivity Disorder and Integrative Approaches. Psychiatric Annals 37:9.
Crossref
Crossref
Asma J Sadiq. (2007) Attention-deficit/Hyperactivity Disorder and Integrative Approaches. Pediatric Annals 36:8, pages 508-515.
Crossref
Crossref
Marianna Mazza, Massimiliano Pomponi, Luigi Janiri, Pietro Bria & Salvatore Mazza. (2007) Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:1, pages 12-26.
Crossref
Crossref
Akhlaq A. Farooqui & Lloyd A. Horrocks. 2007. Glycerophospholipids in the Brain. Glycerophospholipids in the Brain
341
366
.
Keeley J. Brookes, Wai Chen, Xiaohui Xu, Eric Taylor & Philip Asherson. (2006) Association of Fatty Acid Desaturase Genes with Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry 60:10, pages 1053-1061.
Crossref
Crossref
Caryl J. Antalis, Laura J. Stevens, Mary Campbell, Robert Pazdro, Karen Ericson & John R. Burgess. (2006) Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins, Leukotrienes and Essential Fatty Acids 75:4-5, pages 299-308.
Crossref
Crossref
J C Umhau, K M Dauphinais, S H Patel, D A Nahrwold, J R Hibbeln, R R Rawlings & D T George. (2005) The relationship between folate and docosahexaenoic acid in men. European Journal of Clinical Nutrition 60:3, pages 352-357.
Crossref
Crossref
S. Yehuda, S. Rabinovitz & D.I. Mostofsky. (2005) Essential fatty acids and the brain: From infancy to aging. Neurobiology of Aging 26:1, pages 98-102.
Crossref
Crossref
Jennifer Dani, Courtney Burrill & Barbara Demmig‐Adams. (2005) The remarkable role of nutrition in learning and behaviour. Nutrition & Food Science 35:4, pages 258-263.
Crossref
Crossref